United Therapeutics begins litigation with FDA over rival Liquidia’s drug application

United Therapeutics said Wednesday it has filed a lawsuit with the U.S. Food and Drug Administration, alleging that proper procedures were not followed to allow rival Liquidia.

Share This Post: